Scherr DS - Search Results

1

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).

Marciscano AE, Wolfe S, Zhou XK, Barbieri CE, Formenti SC, Hu JC, Molina AM, Nanus DM, Nauseef JT, Scherr DS, Sternberg CN, Tagawa ST, Nagar H. Marciscano AE, et al. Among authors: scherr ds. BMC Cancer. 2023 Aug 22;23(1):781. doi: 10.1186/s12885-023-11278-3. BMC Cancer. 2023. PMID: 37608258 Free PMC article. Clinical Trial.

2

High expression of the Met receptor in prostate cancer metastasis to bone.

Knudsen BS, Gmyrek GA, Inra J, Scherr DS, Vaughan ED, Nanus DM, Kattan MW, Gerald WL, Vande Woude GF. Knudsen BS, et al. Among authors: scherr ds. Urology. 2002 Dec;60(6):1113-7. doi: 10.1016/s0090-4295(02)01954-4. Urology. 2002. PMID: 12475693

3

National Comprehensive Cancer Network guidelines for the management of prostate cancer.

Scherr D, Swindle PW, Scardino PT; National Comprehensive Cancer Network. Scherr D, et al. Urology. 2003 Feb;61(2 Suppl 1):14-24. doi: 10.1016/s0090-4295(02)02395-6. Urology. 2003. PMID: 12667883 Review.

4

Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer.

Boorjian S, Tickoo SK, Mongan NP, Yu H, Bok D, Rando RR, Nanus DM, Scherr DS, Gudas LJ. Boorjian S, et al. Among authors: scherr ds. Clin Cancer Res. 2004 May 15;10(10):3429-37. doi: 10.1158/1078-0432.CCR-03-0756. Clin Cancer Res. 2004. PMID: 15161698

5

Retinoid receptor mRNA expression profiles in human bladder cancer specimens.

Boorjian S, Scherr DS, Mongan NP, Zhuang Y, Nanus DM, Gudas LJ. Boorjian S, et al. Among authors: scherr ds. Int J Oncol. 2005 Apr;26(4):1041-8. Int J Oncol. 2005. PMID: 15754000

6

Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.

Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ. Raman JD, et al. Among authors: scherr ds. Carcinogenesis. 2006 Mar;27(3):499-507. doi: 10.1093/carcin/bgi299. Epub 2005 Dec 12. Carcinogenesis. 2006. PMID: 16344273

7

Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy.

Schwartz MJ, Hwang DH, Hung AJ, Han J, McClain JW, Shemtov MM, Te AE, Sosa RE, Vaughan ED Jr, Scherr DS. Schwartz MJ, et al. Among authors: scherr ds. Cancer. 2008 Apr 15;112(8):1718-25. doi: 10.1002/cncr.23353. Cancer. 2008. PMID: 18330908 Free article.

8

Ureteroileal anastomosis with intraluminal visualization: technique and outcomes.

Barbieri CE, Schwartz MJ, Boorjian SA, Lee MM, Scherr DS. Barbieri CE, et al. Among authors: scherr ds. Urology. 2010 Dec;76(6):1496-500. doi: 10.1016/j.urology.2010.01.035. Epub 2010 Apr 9. Urology. 2010. PMID: 20381836

9

Tissue-based molecular markers for bladder cancer.

Barbieri CE, Lotan Y, Lee RK, Sonpavde G, Karakiewicz PI, Robinson B, Scherr DS, Shariat SF. Barbieri CE, et al. Among authors: scherr ds. Minerva Urol Nefrol. 2010 Sep;62(3):241-58. Minerva Urol Nefrol. 2010. PMID: 20940694 Review.

10

Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.

Barbieri CE, Cha EK, Chromecki TF, Dunning A, Lotan Y, Svatek RS, Scherr DS, Karakiewicz PI, Sun M, Mazumdar M, Shariat SF. Barbieri CE, et al. Among authors: scherr ds. BJU Int. 2012 Mar;109(5):685-90. doi: 10.1111/j.1464-410X.2011.010419.x. Epub 2011 Aug 18. BJU Int. 2012. PMID: 21851550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page